Markus Aebi

Title: Innovations and Contributions of Inventor Markus Aebi

Introduction

Markus Aebi is a prominent inventor based in Wettingen, Switzerland. He has made significant contributions to the field of biochemistry, particularly in the production of glycosylated proteins and novel methyl transferase enzymes. With a total of eight patents to his name, Aebi's work has had a substantial impact on both academic research and practical applications in biotechnology.

Latest Patents

Among his latest patents, Aebi has developed methods for producing glycosylated proteins. These methods are designed for both in vitro and in vivo applications, utilizing host cells to generate glycosylated proteins. Additionally, he has patented a method for producing n-methylated (poly)peptides. This invention focuses on novel methyl transferase enzymes that methylate backbone amides of (poly)peptides. The patent also includes nucleic acids encoding these enzymes, as well as vectors and host cells that incorporate them. Furthermore, Aebi's work encompasses the use of these enzymes for modifying (poly)peptides, highlighting the versatility and potential of his inventions.

Career Highlights

Markus Aebi has had a distinguished career, working with esteemed institutions such as ETH Zurich. His research has not only advanced scientific understanding but has also paved the way for new methodologies in protein production and modification. His innovative approaches have garnered attention in the scientific community, leading to numerous citations and collaborations.

Collaborations

Throughout his career, Aebi has collaborated with notable colleagues, including Umesh Ahuja and Michael T Kowarik. These partnerships have facilitated the exchange of ideas and have contributed to the success of his research endeavors.

Conclusion

Markus Aebi's contributions to the field of biochemistry through his patents and research collaborations underscore his role as a leading inventor. His innovative methods for producing glycosylated proteins and modifying (poly)peptides continue to influence the biotechnology landscape.